Korean Market
MATR
Parataxis Korea
★

Amended Merger Disclosure for Parataxis Korea: Delisting Risk and Schedule Adjustments

 
EXCH
Parataxis Korea
★

Parataxis Korea Calls Temporary Shareholders Meeting to Approve Merger

 
OTHR
Parataxis Korea
★

Parataxis Korea Calls 12th Extraordinary General Meeting to Elect Two Outside Directors

 
EXCH
Parataxis Korea
★

Parataxis Korea Sets Record Date for Extraordinary General Meeting

 
EXCH
Parataxis Korea
★

Parataxis Korea Changes Extraordinary Shareholder Meeting Agenda from Merger to Director Election

 
EXCH
Parataxis Korea
★★

Parataxis Korea Trading Suspension Extended Due to Delisting Reason, Trading Halted at 416 Won

 
EXCH
Parataxis Korea
★★★★★

Parataxis Korea Corporate Examination Committee Decides Delisting, Share Value at Risk

 
EXCH
Parataxis Korea
★

Parataxis Korea Terminates Option Contract for Idiopathic Pulmonary Fibrosis Treatment Candidate, a Strategic Decision

 
EXCH
Parataxis Korea
★

Parataxis Korea Submits Improvement Plan, Facing Delisting Review - Risk of Shareholder Value Decline

 
EXCH
Parataxis Korea
★★★★

Designated for Substantive Review of Listing Eligibility, Trading Suspension Extended Due to Delisting Risk

 
EXCH
Parataxis Korea
★★★★

Parataxis Korea Faces Potential Delisting as Subject to Listing Eligibility Review

 
EXCH
Parataxis Korea
★★★

Listing Eligibility Review Investigation Extended by 15 Business Days, Delisting Risk Persists

 
PERI
Parataxis Korea
★★★

Parataxis Korea Faces Delisting Risk and Merger Amidst Losses

 
EXCH
Parataxis Korea
★★

Derivative Valuation Loss of 5.63 Billion Won, 12.85% of Equity

 
EXCH
Parataxis Korea
★

Correction of Record Date for EGM (2026-06-29→2026-06-26)